Evidence map›Paper›PMID 42555504›Full record

ArticleBriefings in bioinformatics2026

Mitigating negative data bias to enhance TCR-epitope binding and residue interaction prediction.

Xue Mi, Jinghua Zhu, Zhu Dai, Yuheng Zhu, Bo Ding, Hao Lin, Yang Shen, Guochun Cao, Zhongdang Xiao

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. HLA-II Expression Marks Activated and Clonally Expanded CD8International journal of molecular sciences · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xue MiState Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, No. 2 Sipailou, Xuanwu District, Nanjing 210096, China.ORCID 0009-0005-1041-6370
Jinghua ZhuDepartment of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, 42 Baiziting, Xuanwu District, Nanjing 210009, China.
Zhu DaiState Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, No. 2 Sipailou, Xuanwu District, Nanjing 210096, China.
Yuheng ZhuState Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, No. 2 Sipailou, Xuanwu District, Nanjing 210096, China.
Bo DingDepartment of Obstetrics and Gynecology, Zhongda Hospital, School of Medicine, Southeast University, 87 Dingjiaqiao Road, Xuanwu District, Nanjing 210009, China.
Hao LinDepartment of Obstetrics and Gynecology, Zhongda Hospital, School of Medicine, Southeast University, 87 Dingjiaqiao Road, Xuanwu District, Nanjing 210009, China.
Yang ShenDepartment of Obstetrics and Gynecology, Zhongda Hospital, School of Medicine, Southeast University, 87 Dingjiaqiao Road, Xuanwu District, Nanjing 210009, China.ORCID 0000-0002-3313-5062
Guochun CaoDepartment of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, 42 Baiziting, Xuanwu District, Nanjing 210009, China.
Zhongdang XiaoState Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, No. 2 Sipailou, Xuanwu District, Nanjing 210096, China.

Funding

Key Research & Development Program of Jiangsu Province BE2020777National Natural Science Foundation of China 82072078Yishan Plan of Jiangsu Cancer Hospital YSZD202401
6 · The paper itself

Abstract

Accurate prediction of the binding specificity between T-cell receptors (TCRs) and epitopes, along with the elucidation of their molecular interaction mechanisms, is pivotal for advancing immunotherapy and vaccine development. In this study, we propose a negative dataset construction strategy based on region-directed random mutations as an effective complement to traditional negative sampling methods. This strategy preserves the conserved amino acid motifs encoded by the V and J gene segments of the CDR3$\beta$ sequence while introducing key residue mutations within the central junctional region. By constructing hard negatives, this approach encourages the model to capture more discriminative TCR-epitope binding features. Based on this optimized dataset, we developed TranTCR, a computational framework comprising two models: TranTCR-bind, which focuses on global sequence-level binding probability prediction, and TranTCR-map, which leverages transfer learning to translate global binding knowledge into fine-grained characterizations of residue-level interactions, such as inter-residue distances and contact scores. Experimental results demonstrate that TranTCR-bind exhibits superior predictive performance and generalization robustness across various negative sampling protocols. Furthermore, TranTCR-map utilizes attention mechanisms to deeply resolve complex inter-amino acid associations, enabling the identification of latent binding patterns and the revelation of TCR cross-reactivity characteristics. This study provides an efficient computational tool for the high-throughput screening of TCR repertoires and the digital characterization of immune recognition mechanisms.

Indexed as

Computational BiologyEpitopes, T-LymphocyteReceptors, Antigen, T-CellBinding SitesHumansImmunoinformaticsProtein BindingEpitopes, T-LymphocyteReceptors, Antigen, T-Cellbiomedical engineeringdeep learningTCR-epitope

Identifiers

PMID42555504
PMCPMC13440130

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.